Literature DB >> 22381073

Mumps vaccine effectiveness in primary schools and households, the Netherlands, 2008.

Bianca E P Snijders1, Alies van Lier, Jan van de Kassteele, Ewout B Fanoy, Wilhelmina L M Ruijs, Folkwin Hulshof, Annet Blauwhof, Maarten Schipper, Rob van Binnendijk, Hein J Boot, Hester E de Melker, Susan J M Hahné.   

Abstract

To estimate the mumps vaccine effectiveness (VE) during a large genotype D mumps outbreak, we conducted a cross-sectional study in eight primary schools and associated households in the Netherlands. Questionnaires were used to collect information on the occurrence of mumps. Multivariate analyses were used to estimate VE. Among schoolchildren we estimated the VE against mumps. Among household contacts where the schoolchild was the index case we estimated the VE against mumps and against mumps infectiousness. In total 1175 children and 2281 household contacts participated in the study. The mumps attack rate among schoolchildren was 17%. The mumps VE in schoolchildren was 92% [95% confidence interval (CI) 83-96%] and 93% [85-97%] for one and two doses of the measles, mumps, rubella (MMR) vaccine, respectively. The adjusted mumps VE among household contacts was 67% [65-95%] and 11% [-4 to 88%] against mumps and mumps infectiousness, respectively. Our study indicates that the mumps component of the MMR vaccine offered adequate protection against mumps among schoolchildren. The relatively low VE among household contacts is of concern.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22381073     DOI: 10.1016/j.vaccine.2012.02.035

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  13 in total

Review 1.  Mumps: an Update on Outbreaks, Vaccine Efficacy, and Genomic Diversity.

Authors:  Eugene Lam; Jennifer B Rosen; Jane R Zucker
Journal:  Clin Microbiol Rev       Date:  2020-02-26       Impact factor: 26.132

2.  Effectiveness of a Third Dose of MMR Vaccine for Mumps Outbreak Control.

Authors:  Cristina V Cardemil; Rebecca M Dahl; Lisa James; Kathleen Wannemuehler; Howard E Gary; Minesh Shah; Mona Marin; Jacob Riley; Daniel R Feikin; Manisha Patel; Patricia Quinlisk
Journal:  N Engl J Med       Date:  2017-09-07       Impact factor: 91.245

3.  Seroepidemiology of mumps in the general population of Jiangsu province, China after introduction of a one-dose measles-mumps-rubella vaccine.

Authors:  Yuanbao Liu; Ying Hu; Xiuying Deng; Zhiguo Wang; Peishan Lu; Fubao Ma; Minghao Zhou; Pei Liu; Jie Min
Journal:  Sci Rep       Date:  2015-10-01       Impact factor: 4.379

Review 4.  Vaccines for measles, mumps, rubella, and varicella in children.

Authors:  Carlo Di Pietrantonj; Alessandro Rivetti; Pasquale Marchione; Maria Grazia Debalini; Vittorio Demicheli
Journal:  Cochrane Database Syst Rev       Date:  2021-11-22

5.  Estimation of vaccine efficacy and critical vaccination coverage in partially observed outbreaks.

Authors:  Michiel van Boven; Wilhelmina L M Ruijs; Jacco Wallinga; Philip D O'Neill; Susan Hahné
Journal:  PLoS Comput Biol       Date:  2013-05-02       Impact factor: 4.475

6.  Antigenic differences between vaccine and circulating wild-type mumps viruses decreases neutralization capacity of vaccine-induced antibodies.

Authors:  M Šantak; M Lang-Balija; J Ivancic-Jelecki; T Košutić-Gulija; S Ljubin-Sternak; D Forcic
Journal:  Epidemiol Infect       Date:  2012-09-07       Impact factor: 4.434

7.  Vaccines for measles, mumps, rubella, and varicella in children.

Authors:  Carlo Di Pietrantonj; Alessandro Rivetti; Pasquale Marchione; Maria Grazia Debalini; Vittorio Demicheli
Journal:  Cochrane Database Syst Rev       Date:  2020-04-20

8.  Waning Immunity Is Associated with Periodic Large Outbreaks of Mumps: A Mathematical Modeling Study of Scottish Data.

Authors:  Dalila Hamami; Ross Cameron; Kevin G Pollock; Carron Shankland
Journal:  Front Physiol       Date:  2017-04-25       Impact factor: 4.566

Review 9.  Mumps in the Vaccination Age: Global Epidemiology and the Situation in Germany.

Authors:  Andrea-Ioana Beleni; Stefan Borgmann
Journal:  Int J Environ Res Public Health       Date:  2018-07-31       Impact factor: 3.390

10.  Epidemic of mumps among vaccinated persons, The Netherlands, 2009-2012.

Authors:  Jussi Sane; Sigrid Gouma; Marion Koopmans; Hester de Melker; Corien Swaan; Rob van Binnendijk; Susan Hahné
Journal:  Emerg Infect Dis       Date:  2014-04       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.